Hagen Rachael, Nguyen Minh Thu T, Thorarensen Stefan, Pillai Ashwin, Parikh Neil
Internal Medicine, University of Connecticut Health, Farmington, USA.
Gastroenterology and Hepatology, University of Connecticut, Farmington, USA.
Cureus. 2025 Mar 11;17(3):e80423. doi: 10.7759/cureus.80423. eCollection 2025 Mar.
Mirizzi syndrome (MS) occurs in cholelithiasis when gallstones obstruct the cystic duct or neck of the gallbladder, leading to compression of the common hepatic duct (CHD) and potentially causing ductal obstruction. This may result in the formation of a cholecystocholedochal fistula. Open cholecystectomy is the standard treatment. We present a case of MS in a heart transplant candidate, managed with stent placement and percutaneous cholecystostomy due to his high surgical risk. His course was complicated by stent migration. This case underscores how MS can be effectively managed with stent placement and percutaneous cholecystostomy.
Mirizzi综合征（MS）发生于胆石症时，胆结石阻塞胆囊管或胆囊颈部，导致肝总管（CHD）受压并可能引起胆管梗阻。这可能导致胆囊胆总管瘘的形成。开腹胆囊切除术是标准治疗方法。我们报告一例等待心脏移植的患者发生MS，因其手术风险高，采用支架置入和经皮胆囊造瘘术治疗。其病程因支架移位而复杂化。该病例强调了MS如何通过支架置入和经皮胆囊造瘘术得到有效治疗。
